Clinical Trials

Transplantation

  1. Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial - EXTended Criteria Donors
    PI Dr. Richard Formica
  2. Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial
    PI Dr. Richard Formica
  3. A Randomized, Open-Label Study to Compare the Safety and Efficacy of Two Different Sirolimus Regimens With a Tacrolimus + Mycophenolte Mofetil regimen in De Novo renal Allograft Recipients
    Pi Dr. Sanjay Kulkarni
  4. Noninvasive Monitoring to Predict Outcome in De Novo Kidney Transplant Recipients
    Pi Richard Formica
  5. A Randomized, Open-Label, Comparative Evaluation of Conversion from Calcineurin Inhibitors to Sirolimus Versus Continued Use of Calcineurin Inhibitors in Renal Allograft Recipients.
    PI Dr. Sanjay Kulkarni
  6. A facilitated access program to provide Everolimus (RAD) for maintenance patients completing therapy in RAD trials in solid organ transplantation (RAD 2401)
    Pi Dr. Richard Formica

Oncology

  1. Open Label, Two-Stage, Phase II Study to Evaluate the Efficacy and Tolerability of ZD6474 in Patients with Locally Advanced or Metastatic Hereditary Medullary Thyroid Carcinoma.
  2. An International, Phase II, Randomized, Double-Blinded, Placebo-Controlled, Multi-Center Study to Assess the Efficacy of ZD6474 (Zactima) verses Placebo in Subjects with Unresectable Locally Advanced or Metastatic Medullary Thyroid Cancer.

View more Yale trials…